Trevi Therapeutics Capital Expenditures (CapEx) Growth & History (TRVI)
Trevi Therapeutics's capital expenditures (capex) was $12,000 for fiscal 2025.
View full Trevi Therapeutics company overviewTrevi Therapeutics annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $12,000 | −$23,000 | −65.71% |
| 2024 | 2024-12-31 | $35,000 | −$102,000 | −74.45% |
| 2023 | 2023-12-31 | $137,000 | −$22,000 | −13.84% |
| 2022 | 2022-12-31 | $159,000 | — | — |
| 2020 | 2020-12-31 | $32,000 | $23,000 | +255.56% |
| 2019 | 2019-12-31 | $9,000 | −$149,000 | −94.30% |
| 2018 | 2018-12-31 | $158,000 | — | — |
Trevi Therapeutics quarterly capital expenditures (capex)
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $124,000 | — | — |
| Q1 2026 | 2026-03-31 | $102,000 | — | — |
| Q3 2025 | 2025-09-30 | $12,000 | $12,000 | — |
| Q4 2024 | 2024-12-31 | $7,000 | −$15,000 | −68.18% |
| Q3 2024 | 2024-09-30 | $0 | −$18,000 | — |
| Q4 2023 | 2023-12-31 | $22,000 | — | — |
| Q3 2023 | 2023-09-30 | $18,000 | — | — |
| Q2 2023 | 2023-06-30 | $40,000 | — | — |
| Q1 2023 | 2023-03-31 | $57,000 | — | — |
| Q3 2020 | 2020-09-30 | $15,000 | $15,000 | — |
| Q4 2019 | 2019-12-31 | $0 | −$92,000 | — |
| Q3 2019 | 2019-09-30 | $0 | −$1,000 | — |
| Q2 2019 | 2019-06-30 | $0 | −$10,000 | — |
| Q1 2019 | 2019-03-31 | $9,000 | −$48,000 | −84.21% |
| Q4 2018 | 2018-12-31 | $92,000 | — | — |
| Q3 2018 | 2018-09-30 | $1,000 | — | — |
| Q2 2018 | 2018-06-30 | $10,000 | — | — |
| Q1 2018 | 2018-03-31 | $57,000 | — | — |
Trevi Therapeutics capital expenditures (capex) trends
Over the last five fiscal years, Trevi Therapeutics's capital expenditures (capex) decreased from $32,000 to $12,000, a change of −$20,000. The latest reported quarter, Q2 2026, shows $124,000.
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Trevi Therapeutics source filings ↗